POLL: Are You Attending the 2023 Annual Meeting of the American College of Mohs Surgery in Seattle?
FDA Gives the Green Light for Cheek Wrinkle Solution
Galderma announced the approval of a injectable poly-L-lactic acid to correct fine lines and wrinkles.
Spesolimab-sbzo Receives a New, Permanent J-code
Mark Lebwohl, MD said it is a step forward for patients diagnosed with generalized pustular psoriasis.
Phase 2 KEYNOTE-695 Trial for Melanoma Treatment Did Not Reach Primary Endpoint
Patients in the clinical trial had confirmed disease progression after 12 weeks.
The Connection Between COVID Lung Lesions and Skin Lesions
Jack Arbiser, MD, PhD conducted research in a recent study to observe the impact R-propranolol has on broad-spectrum anti-coronavirus activity.
Discovering Dermatology Times: March 2023
Learn more about the in-depth topics covered in the March 2023 issue of Dermatology Times®.
Breast Care for Pregnant and Lactating Patients
When a patient complains of breast pain, there are several special considerations for diagnosis and treatment.
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The investigational oral JAK1 inhibitor showed promising results for vitiligo patients.
Highlights from AAD 2023
More than 300 innovative sessions, an engaging exhibit hall, and heartfelt networking—there was a lot to pack into AAD 2023! Here are the highlights.
AAD 2023 Pearls from Zoe Diana Draelos, MD
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
A pediatric dermatologist and pediatric allergist translated guidelines into clinical practice at AAD 2023.
Skin Barrier 101: Keep Up with What Your Patients Are Reading
Jack Arbiser, MD, PhD discusses the connection between the skin barrier and anti-aging products.
POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?
This question drummed up discussion during one AAD 2023 session on the topic. We want to hear from you!
Tips to Organize the Digital Chaos with Alina Bridges, DO
In a world where she practices dermatology, conducts research, and is a super mom, Alina Bridges, DO has nailed down a strategy to not let emails stress her out.
Treating the Chest with Care on a Transgender Patient
A review on breast cancer screenings and procedures on the chest is essential to ensure proper gender-affirming care.
Establishing a Culture of Respect: Responding to Patient-Initiated Harassment
The impacts of discrimination, harassment, and microaggressions have lasting impact on a clinician’s performance, mental health, and career. Here’s how to create a respectful culture.
New Data Shows Promising Results in Treatment of Hand and Foot Atopic Dermatitis
The latest phase 3 trial results were showcased in an AAD late-breaking research session.
The Power of Patch Testing With Peggy Wu, MD
Wu delves into her AAD involvement as she presents in sessions centered around the importance of patch testing and how clinical guidelines are created.
Alina Bridges, DO Shares Importance of Immunofluorescence
She and her colleagues illustrated the role of direct immunofluorescence plays in the evaluation of autoimmune blistering disorders.
Top Takeaways from the 19th Annual Skin of Color Scientific Symposium
The Skin of Color Society challenged dermatologists, residents, and medical students to address racial disparities in dermatologic care and shared best practices to serve patients of color.
AAD 2023 Meeting Coverage to Look Forward To
The Dermatology Times® team is in New Orleans, Louisiana to showcase innovative solutions in dermatologic care.
Solutions for Challenging Mohs Reconstructive Surgeries
Anna Bar, MD, FAAD returns to AAD as part of the interactive “How Would You Reconstruct It?” session.
PREVIEW: 19th Annual Skin of Color Scientific Symposium
In conjunction with AAD 2023, the Skin of Color Society presents an opportunity to learn about racial disparities in dermatologic care and best practices to serve patients of color.
Confidence Confirmed for Atopic Dermatitis Treatment
Treatment safety and efficacy for atopic dermatitis has seen significant growth over the last decade.
New Study Shows Prevalence of Alopecia Areata in People of Color
The findings of this cross-sectional study indicate alopecia areata, alopecia totalis, and alopecia universalis is more common in people of color, particularly Asian Americans.
Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship
The AbbVie company announced their partnership with the grant program to encourage women to own their own businesses.
FDA Reviewing Dupilumab for Chronic Spontaneous Urticaria
The treatment for adults and adolescents with the type 2 inflammatory skin condition has been accepted for FDA review.
Basal Cell Carcinoma Removed From President Biden’s Chest
The commander-in-chief’s cancerous tissue was successfully removed last month.
Looking at 5 Rare Skin Conditions
Today is Rare Disease Day. The Food and Drug Administration (FDA) defined a rare disease as a condition affecting less than 200,000 people in the United States.
IDP-126 Gel Shows Promising Results In Moderate-to-Severe Acne Treatment
Study participants saw a rapid decrease in inflammatory lesions with the once-daily antibiotic, antibacterial, and retinoid gel.